Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen.

Source:http://linkedlifedata.com/resource/pubmed/id/9518880

Download in:

View as

General Info

PMID
9518880